Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zegalogue® (dasiglucagon) – New drug approval
March 23, 2021 - Zealand Pharma announced the FDA approval of Zegalogue (dasiglucagon), for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above.
